COVID-19

Dear Partners,

Necessitated by the unprecedented situation created by Covid-19, several industry events and tradeshows across the world have been postponed or stand cancelled. While we were looking forward to meet you, we at Piramal Pharma Solutions have had to take several precautionary measures to protect both our employees and customers, worldwide.

As we move forward in these extraordinary times, we want to assure you that that we are operational by taking the right safety measures and abundant precautions to ensure that we continue to support you and your patients.

While all of us are working remotely for now, you can schedule a discussion with us and we would be glad to help ensure you meet your pharmaceutical development and supply needs and thereby, your clinical and commercial timelines.

Please feel free to reach out to us at:
Stuart.Needleman@piramal.com

Our best wishes to colleagues, friends and family.

Best Regards,
Piramal Pharma Solutions

PiramalPharma Solutions Logo

Pharmaceutical Solid-state Characterization: Routes for Meaningful Interpretation

13 Feb 2024

Pharmaceutical Solid-state Characterization: Routes for Meaningful Interpretation

Mitigating Risks in Tech Transfers and Site Transfers

20 Oct 2023

Mitigating Risks in Tech Transfers and Site Transfers

Protacs: Accessing the Expertise Needed to Drug the Undruggable

20 Oct 2023

Protacs: Accessing the Expertise Needed to Drug the Undruggable

saRNA From Mammalian Cell Lines (Hek 293f & Vero) as a Delivery System for Gene Therapy Products

29 Aug 2023

saRNA From Mammalian Cell Lines (Hek 293f & Vero) as a Delivery System for Gene Therapy Products

Production of AAV2 Particles for Gene Therapy Applications

28 Jul 2023

Production of AAV2 Particles for Gene Therapy Applications

Modulating Atropisomers to Optimize the Biological Activity of Challenging Drug Molecules

08 Jun 2023

Modulating Atropisomers to Optimize the Biological Activity of Challenging Drug Molecules